PATIENT INFORMATION LEAFLET FOR FEDALOC 30 mg / 60 mg SR TABLETS. Please read this leaflet carefully before you start taking FEDALOC tablets.

Similar documents
PATIENT INFORMATION LEAFLET FEDALOC RANGE

Read this entire leaflet carefully before you start taking DYNA BEZAFIBRATE. If you have further questions, please ask your doctor or your pharmacist.

PATIENT INFORMATION LEAFLET SIMVACOR RANGE

PATIENT INFORMATION LEAFLET AMLOC RANGE

PATIENT INFORMATION LEAFLET FOR TEXA 10 mg TABLETS AND TEXA SYRUP PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM:

This leaflet is for Adalat tablets. It is different from the leaflet for another form of Adalat known as Adalat Oros.

PATIENT INFORMATION LEAFLET ZYTOMIL RANGE

PATIENT INFORMATION LEAFLET DYNAFIL RANGE

PATIENT INFORMATION LEAFLET PEPLOC RANGE

PATIENT INFORMATION LEAFLET

PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM: Read this entire leaflet carefully before you start taking DYNAFLOC.

PATIENT INFORMATION LEAFLET TEXAMER

This leaflet answers some common questions about Adefin 10 and Adefin 20 tablets (described below as Adefin tablets).

PATIENT INFORMATION LEAFLET CARVETREND RANGE

PACKAGE LEAFLET: INFORMATION FOR THE USER. Lercanidipine 10 mg film-coated tablets Lercanidipine 20 mg film-coated tablets

PATIENT INFORMATION LEAFLET POLLENTYME S AND TABS

POLLENTYME S and Tabs Pharma Dynamics (Pty) Ltd Version: July 2017 (G1639) Word copy of G1639 PATIENT INFORMATION LEAFLET FOR POLLENTYME S AND TABS

PATIENT INFORMATION LEAFLET SINTAIR RANGE

PATIENT INFORMATION LEAFLET DYNARB RANGE

Package leaflet: Information for the patient. Felodipin AstraZeneca 10 mg prolonged-release tablets. felodipine

PATIENT INFORMATION LEAFLET: Lancap 15 mg and 30 mg. Please read this leaflet carefully before taking LANCAP capsules.

Adefin XL contains the active ingredient nifedipine

PATIENT INFORMATION LEAFLET ZOXADON TABLETS RANGE

PATIENT INFORMATION LEAFLET BILOCOR RANGE

PATIENT INFORMATION LEAFLET CARZIN XL

1. WHAT OXCARBAZEPINE IS AND WHAT IT IS USED FOR

PATIENT INFORMATION LEAFLET PEARINDA PLUS

ADALAT OROS (Add-a-lat Or-us) nifedipine

APO-Lercanidipine Tablets Contains the active ingredient, lercanidipine (as lercanidipine hydrochloride)

Motens 2 mg and 4 mg Tablets lacidipine

PHARMA DYNAMICS CLOPIDOGREL 75 mg PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET EFFERFLU C IMMUNE BOOSTER. EFFERFLU C IMMUNE BOOSTER has not been evaluated by the Medicines Control

CORDIPIN RETARD 20 mg Prolonged-release tablets

This leaflet answers some common questions about Momex SR Tablets.

PACKAGE LEAFLET: INFORMATION FOR THE USER

ATORIS 10, 20, 40 mg film-coated tablets

Colofac mebeverine hydrochloride

How Entecavir GH Works

Flecainide BNM. Please read this leaflet carefully before you start taking Flecainide BNM.

Adalat retard 10 mg Modified-release tablets Nifedipine

Chemmart Atorvastatin Contains the active ingredient, atorvastatin calcium

Onglyza CONSUMER MEDICINE INFORMATION

Package leaflet: Information for the patient. Lercan 10 mg film-coated tablets Lercan 20 mg film-coated tablets. Lercanidipine hydrochloride

Sanomigran 500 microgram Tablets and Sanomigran 1.5 mg Tablets

Patient Information leaflet

PACKAGE LEAFLET INFORMATION FOR THE USER. Cimetidine 200mg Tablets Cimetidine 400mg Tablets Cimetidine 800mg Tablets (Cimetidine)

Package leaflet: Information for the patient. Risedronate sodium 35 mg film-coated tablets. Risedronate sodium

CONSUMER MEDICINE INFORMATION

APO-Ondansetron Contains the active ingredient, ondansetron (as hydrochloride dihydrate)

Adalat LA 60 mg Prolonged-release tablets Nifedipine

Package leaflet: Information for the user Coracten SR Capsules 10 mg and Coracten SR Capsules 20 mg Nifedipine

MIDAZOLAM APOTEX Solution for Injection Contains the active ingredient midazolam

PATIENT INFORMATION LEAFLET

Epilepsy is a condition where you have repeated seizures (fits). There are many different types of seizures, ranging from mild to severe.

Package leaflet: Information for the user. Ebateva 20 mg Orodispersible Tablets. Ebastine

Blooms The Chemist Atorvastatin

Stada Atorvastatin tablets Atorvastatin calcium

PATIENT INFORMATION LEAFLET

Consumer Medicine Information

SANDOMIGRAN. 0.5mg tablet Pizotifen malate

Read all of this leaflet carefully before you start taking this medicine.

Otezla (apremilast) film coated tablets

Consumer Medicine Information

Package leaflet: Information for the user. Pravastatin Actavis 20 mg and 40 mg tablets (pravastatin sodium)

SPASMEX FORTE 5mg tablets

Bisacodyl Laxative (Pharmacy Health)

Contains the active ingredient levonorgestrel. For a copy of a large print leaflet, Ph:

Package leaflet: Information for the user. Uniphyllin Continus 200 mg, 300 mg and 400 mg prolonged-release tablets Theophylline

Dulcolax Tablets and Dulcolax Suppositories Bisacodyl

This leaflet answers some of the common questions people ask about Pharmacor Omeprazole.

Ceclor CD cefaclor monohydrate sustained release tablets

PATIENT INFORMATION LEAFLET

PACKAGE LEAFLET: INFORMATION FOR THE USER. XIFAXANTA 200 mg film-coated tablets Rifaximin

What is in this leaflet

APO-Atorvastatin Contains the active ingredient, atorvastatin calcium trihydrate

Package leaflet: Information for the patient. Plenadren 5 mg modified-release tablets Plenadren 20 mg modified-release tablets Hydrocortisone

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. ILAXTEN 20 MG TABLETS bilastine

Ranitidine GH ranitidine hydrochloride film-coated tablets

LORSTAT Atorvastatin (as calcium trihydrate) tablets

PACKAGE LEAFLET INFORMATION FOR THE USER. Cimetidine 800mg Tablets. Cimetidine 400mg Tablets. (Cimetidine)

PACKAGE LEAFLET: INFORMATION FOR THE USER Histabentine 8 mg/16 mg tablets. Betahistine dihydrochloride

PATIENT INFORMATION LEAFLET DYNATOR RANGE

High cholesterol is more likely to occur with certain diseases or if you have a family history of high cholesterol.

2. What you need to know before you take Bisoprolol Tablets

APO-Topiramate tablets Contains the active ingredient topiramate

TRAMAL SR Sustained Release Tablets

BOSLEER CONSUMER MEDICINE INFORMATION

DIXARIT 25 mcg Tablets Clonidine Hydrochloride

PACKAGE LEAFLET: INFORMATION FOR THE USER. Risedronat Jubilant 35 mg film-coated tablets risedronate sodium

This leaflet answers some common questions about Lipidil.

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. AZITHROMYCIN Azithromycin Tablets

Indopril perindopril. Consumer Medicine Information (CMI) What is in this leaflet. What INDOPRIL is used for

PATIENT INFORMATION LEAFLET BILOCOR CO RANGE

NEXIUM INTRAVENOUS esomeprazole sodium

Adalat 5 mg Soft capsules Nifedipine

RANIBOS 150mg Film-coated tablets; 300mg Film-coated tablets

PATIENT INFORMATION LEAFLET. PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM LUMIGAN 0,01 %, bimatoprost 0,1 mg/ml eye drops

Transcription:

1 Module 1.5.5.2 Patient information leaflet PATIENT INFORMATION LEAFLET FOR FEDALOC 30 mg / 60 mg SR TABLETS Please read this leaflet carefully before you start taking FEDALOC tablets. Keep this leaflet. You may need to read it again. It does not contain all the available information about your medicine. If you have further questions, please ask your doctor or your pharmacist. FEDALOC SR has been prescribed for you personally and you should not share your medicine with other people. It may harm them, even if their symptoms are the same as yours. SCHEDULING STATUS Schedule 3. PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM FEDALOC 30 mg SR (slow release film coated tablets) FEDALOC 60 mg SR (slow release film coated tablets) 1. WHAT FEDALOC SR CONTAINS Active ingredients: FEDALOC 30 mg SR: Each slow release tablet contains 30 mg nifedipine. FEDALOC 60 mg SR: Each slow release tablet contains 60 mg nifedipine. Inactive ingredients: Purified talc, povidone, methylene chloride, purified water, lactose monohydrate, hydroxypropylmethylcellulose, carbomer, silica colloidal anhydrous, magnesium stearate.

2 2. WHAT FEDALOC SR IS USED FOR? Treatment of mild to moderate high blood pressure. Preventative treatment (prophylaxis) and treatment of chronic stable angina pectoris (type of chest pain). 3. BEFORE YOU TAKE FEDALOC SR Do not take FEDALOC SR: If you are allergic (hypersensitive) to nifedipine or any other (see "WHAT FEDALOC SR CONTAINS"). If you suffer from liver problems. If you have low blood pressure (light headedness or dizziness). If you have a slow heart rate. If you had a heart attack in the last 4 weeks. If you have a heart condition called angina (chest pain) which is stable and may lead to a heart attack. If you have a blockage in your throat or a narrowing in any part of you digestive system. If you are currently experiencing a heart disorder called cardiogenic shock. If you have a condition called inflammatory bowel disease. If you have a condition called porphyria. If you are taking rifampicin (used in the treatment of tuberculosis (TB)). FEDALOC SR is not recommended for use in children. Take special care with FEDALOC SR: If you have low blood pressure (light headedness or dizziness). If you have any other heart disorders. If you stop treatment with FEDALOC SR suddenly. It may increase the incidence of angina (a heart disorder). If you suffer from liver problems.

3 If you experience heart pain after taking FEDALOC SR. Your doctor may need to stop FEDALOC SR treatment. Your doctor will need to monitor your blood pressure when you start taking FEDALOC SR or when your dose is adjusted. FEDALOC SR is not a replacement for nitroglycerine tablets, taken under the tongue, in an acute attack of angina (chest pain). If you are lactose intolerant (when you are unable to digest lactose, a sugar found in milk). Taking FEDALOC SR with food or drink: FEDALOC SR tablets should be swallowed whole with a glass of water. The tablets should not be divided, chewed or crushed. FEDALOC SR may be taken with or without food. Grapefruit juice: You should not take grapefruit juice while on treatment with FEDALOC SR Pregnancy and breastfeeding: Do not take FEDALOC SR tablets if you are pregnant, planning to become pregnant or breastfeeding. Please consult your doctor if you suspect you are pregnant. Driving and using machinery: FEDALOC SR tablets may cause dizziness or light headedness. Do not drive, operate machinery, or do anything else that could be dangerous until you know how FEDALOC SR tablets affect you. Taking other medicines with FEDALOC SR: Consult your doctor, pharmacist or healthcare professional for advice if you need to take any other medicines. If you are taking other medicines on a regular basis, including complementary or traditional medicines, the use of FEDALOC SR with these medicines may cause undesirable interactions.

4 Do not use the following medicines in combination with FEDALOC SR: Digoxin (used in the treatment of heart disorders). Phenytoin (used in the treatment of epilepsy or seizures/fits). Quinidine (used to treat an irregular heartbeat). Quinupristin / dalfopristin (a combination antibiotic for certain types of infections). Cimetidine (used to treat stomach ulcers or heartburn). Rifampicin (used to treat tuberculosis (TB). Diltiazem (used to treat high blood pressure and certain heart disorders). Erythromycin (an antibiotic used to treat certain types of infections). Fluoxetine (used to treat depression). lndinavir, ritonavir, saquinavir (used in the management of HIV). Ketoconazole, itraconazole, fluconazole (used to treat fungus infections). Carbamazepine (used to treat epilepsy or seizures/fits). Tacrolimus (used to suppress the immune system in organ transplants). Nefazodone (used to treat depression). Phenobarbitone (used to treat epilepsy or seizures/fits). Valproic acid (used to treat epilepsy or seizures/fits). 4. HOW TO TAKE FEDALOC SR FEDALOC SR tablets should be swallowed whole with a glass of fluid. The tablets should not be divided, chewed or crushed. The tablets should be taken at approximately 24 hour intervals, i.e. at the same time each day, preferably in the morning. FEDALOC SR may be taken with or without food. The recommended dosage is 30 mg (one tablet) once daily. This dosage may be increased by your doctor to a maximum of 90 mg once daily. If you are not sure how many tablets to take, ask your doctor or pharmacist.

5 If you take more FEDALOC SR than you should: In the event of overdose, contact your doctor or pharmacist. If neither is available, contact the nearest hospital or poison centre immediately. Take this leaflet and any remaining tablets with you, so that the doctor knows what you have taken. If you forget to take your FEDALOC SR: If you forget to take your medicine, take the missed dose as soon as you remember. However, if it is almost time for you next dose, continue to take the next tablet at the usual time. Do not take a double dose to make up for missed doses. 5. POSSIBLE SIDE EFFECTS FEDALOC SR may cause side effects. Not all side effects reported for FEDALOC SR is included in this leaflet. Should your general health worsen while taking FEDALOC SR, please consult your doctor, pharmacist or other health care professional for advice. Check with your doctor if any of the following side effects continue or are bothersome which may occur frequently: Swelling of the limbs. Nausea. Headache. Less frequent side effects that may occur include the following: Chest pain. Abnormal heartbeat. Eye pain, vision disorders. Constipation.

6 Dizziness, light-headedness. Changes in your mood (feeling unhappy). Increased frequency of urination. Skin rash. Fever. Exhaustion. 6. STORING AND DISPOSING OF FEDALOC SR Store below 25 C. Keep the container tightly closed. Keep the blister in the outer carton until required for use. Protect from light and moisture. KEEP ALL MEDICINES OUT OF REACH AND SIGHT OF CHILDREN. Do not use after the expiry date printed on the label or carton. Return all unused medicine to your pharmacist. Do not dispose of unused medicine in drains and sewerage systems (e.g. toilets). 7. PRESENTATION OF FEDALOC SR White polypropylene securitainers with a white snap-on lid containing 30 or 100 tablets. Opaque white, PVC/PVDC/ Aluminium foil blisters containing 28 tablets in an outer carton. Opaque white, PVC/PVDC/ Aluminium foil blisters containing 30 tablets in an outer carton. 8. IDENTIFICATION OF FEDALOC SR FEDALOC 30 mg SR: Round, biconvex, pale red colour, marked "30" on one side, film coated tablets in a controlled release formulation. Diameter: 7,00 mm. FEDALOC 60 mg SR: Round, biconvex, pale red colour, marked "60" on one side, film coated tablets in a controlled release formulation. Diameter: 11,00 mm.

7 9. REGISTRATION NUMBERS FEDALOC 30 mg SR: 37/7.1/0302 FEDALOC 60 mg SR: 37/7.1/0303 10. NAME AND ADDRESS OF REGISTRATION HOLDER PHARMA DYNAMICS (PTY) LTD. F02 Grapevine House, Steenberg Office Park, Westlake, Cape Town, 7945 11. DATE OF PUBLICATION August 2013